% | $
Quotes you view appear here for quick access.

Oncolytics Biotech, Inc. Message Board

btisaclown 4 posts  |  Last Activity: Feb 8, 2016 5:32 PM Member since: Jun 21, 2012
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • go to the presentation on pg 13 she id's some doc retrospective of CS at 736 days (unsure whether gen 1 or gen 2 or combo) and PFS at 310 days but she indicated some BAC type treatments only gave 286 days OS...and i assume this is all median and not even on PFS vs. OS CS beats em cold...

    ..but here is the crux of Jenny's on the Block failure..she needs $80M in funding to get to approval (give or take of her timeline) $30-35M for PIII and the rest to run the business.. that is about 2 times what DCTH would need to run a comparable PFS based trial..

    ..twice as much, twice as long to get to the same conclusion for approval CS is effective and is safe... why would the market fund double the cost to get to is just goofy from so many ways, makes you think she musta been a government employee

  • Reply to

    Simple question to ask

    by nochair9999 Feb 1, 2016 1:24 PM
    btisaclown btisaclown Feb 8, 2016 12:45 PM Flag

    davey, who are you posting to??? the only acceptable MB protocal is to name the NIC you are addressing in the 1st line of your post...and that failure on you part is likely telling on a whole bunch of other stuff...but yes while i am constantly right as always, i do know a lot about trial design compared to you and have dumped many a baby biotech on bad trial design (and have been typically proven correct)..for instance, dumped one mid-last year a supposed PIII worldwide trial with supposed FDA and EU clearance (pumped interestingly as the company was raising money (hmmm i wonder if that was fraud)) suddenly after raise the FDA role disappeared off presentations.. i sold first itme i saw and have watched the stock decline constantly since then...trial design and parameters matter to those who like me "know"

  • Jenny, you have overseen a 90% destruction of share price, IMO you are getting a pass so far primarily because you are a women, as the sum of your CEO decisions is well very very bad.... today is delisting day...

    ...IMO in your D&P today you really need to id why the goofy PIII is valuable...and most important to need to id what any good an interim may provide

    ...2ndly you need to id why EU reimbursement will be a good thing

    ..3rd a proper update on HCC/ICC would be helpful, not this lame well a lot trials are doing HCC/ICC..these are timelines you touted and as they are way wrong i conclude you are incompetent or lack proper experience...HCC has been a crowded space before DCTH started their P2 trial, etc., etc.

    ..but how long before an interim...

  • well run companies simply don't fail like this and it is embarrassing for DCTH...

    on their site under events they id todays BIO CEO conference being delivered at 2:30 am...yepper i betcha they dog and ponied to an empty room if true..

    ..and if they can't get that right i am correct to believe they couldn't get the goofy PIII in OM correct...

    ..cmon Jenny's on the Block pull up your panty hose and get these things right

0.330.00(0.00%)Nov 4 4:00 PMEST